Primary Record
Ivacaftor
- In stock
- 7,432 g
- Purity
- 98.7 %
- CAS
- 873054-44-5
Compound Identifiers & Properties
- CAS
- 873054-44-5
- PubChem CID
- 16220172
- SMILES
- CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C
- Canonical SMILES
- CC(C)(C)c1cc(C(C)(C)C)c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O
Names & Synonyms
- Ivacaftor
- Kalydeco
- 873054-44-5
- Ivacaftor (VX-770)
- VX-770
- ivacaftorum
- Ivacaftor-d18
- Deutivacaftor
- Kalydeco (TN)
- Ivacaftor [USAN]
- Ivacaftor Impurity
- Ivacaftor D18
- Ivacaftor-[d18]
- Ivacaftor [USAN:INN]
- N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide
- Tube715
- IVACAFTOR [INN]
- RefChem:58494
- IVACAFTOR [MI]
- Ivacaftor (USAN/INN)
- VX 770
- VX-770 - Ivacaftor
- 1Y740ILL1Z
- IVACAFTOR [VANDF]
- UNII-1Y740ILL1Z
- VX770
- MFCD17171361
- CHEBI:66901
- D0W7WC
- Ivacaftor - 25MG 25mg
- IVACAFTOR [WHO-DD]
- C24H28N2O3
- Ivacaftor (4-tertbutyl-d9)
- cc-231
- MLS006011119
- SCHEMBL351373
- SCHEMBL417309
- DTXSID00236281
- ORKAMBI COMPONENT IVACAFTOR
- SYMKEVI COMPONENT IVACAFTOR
- GTPL4342
- orb1305294
- QUI135
- TRIKAFTA COMPONENT IVACAFTOR
- IVACAFTOR [ORANGE BOOK]
- VX-770, Ivacaftor, Kalydeco
- CHEMBL2010601
- SCHEMBL29357389
- SCHEMBL29379239
- DTXCID00158772
- EX-A441
- QCR-155
- R07AX02
- N-[2,4-Bis(tert-butyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-3-quinolinecarboxamide
- PURKAOJPTOLRMP-UHFFFAOYSA-N
- s1144
- BCPP000199
- HMS3654E10
- HMS3744K05
- HMS5079A11
- AOB31714
- BCP19794
- NGC43107
- ABP000259
- BDBM50032693
- EBC-11412
- VX-770/VX770
- ZINC52509463
- Ivacaftor (4-tertbutyl-d9) (Major)
- AKOS015994762
- AKOS032950001
- C24-H28-N2-O3
- Elexacaftor, Tezacaftor, and Ivacaftor
- BCP9000799
- BLP-012401
- CCG-268562
- CS-0497
- DB08820
- EX-7211
- LE-0002
- SB16815
- KS-0000063W
- compound 48 [PMID: 25441013]
- NCGC00242480-01
- NCGC00242480-03
- 4CA-0661
- AC-28324
- AK170457
- AN-16981
- BC660099
- CID:16220172
- DA-54489
- FI143182
- HY-13017
- SC-95534
- SMR004702900
- SY067891
- SID:135653729
- 1413431-05-6
- AB0008116
- AB2000007
- N-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1H-quinoline-3-carboxamide
- A5047
- FT-0696681
- NS00009974
- SW219620-1
- X7565
- EC-000.2478
- J3.163.539J
- A10985
- A25626
- D09916
- W-5681
- AB01565806_02
- EN300-7400944
- C545203
- F468426
- Q6095693
- 3-Quinolinecarboxamide, N-(2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl)-1,4-dihydro-4-oxo-
- BRD-K52818472-001-02-2
- VX770, VX 770, Ivacaftor, 873054-44-5
- Z2146566713
- 3-Quinolinecarboxamide, N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-
- B0084-286767
- CTP-656; CTP-656; CTP-656; d9-ivacaftor;VX-561
- N-(2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide
- 1413431-07-8
- Cystic Fibrosis Transmembrane Conductance Regulator Potentiator
- N-(2,4-ditert-butyl-5-hydroxy-phenyl)-4-oxo-1H-quinoline-3-carboxamide
- N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-1,4-dihydro-4-oxoquinoline-3-carboxamide
- N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-4-oxo-1H-quinoline-3-carboxamide
- N-(5-hydroxy-2,4-ditert-butyl-phenyl)-4-oxo-1H-quinoline-3-carboxamide
- N-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide
- N-(5-Hydroxy-2,4-bis(2-methyl-2-propanyl)phenyl]-4-oxo-1,4-dihydro-3-quinolinecarboxamide
- N-(5-Hydroxy-2,4-di-tert-butylphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide
- N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
- N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-4-oxo-1,4-dihydroquinoline-3-carboxamide
- N-[2,4-Bis[1,1-di(methyl)ethyl]-5-hydroxyphenyl]-1,4-dihydro-4-oxo-3-quinolinecarboxamide
- 1134822-00-6
- 3-Quinolinecarboxamide, N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-; N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-3-quinolinecarboxamide; Ivacaftor; Kalydeco; N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide; N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide; VX 770
- 800-027-5
- Kalydeco|||N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-3-quinolinecarboxamide
- VX7